Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Four Cycles of Etoposide plus Cisplatin for Patients with
Good‐Risk
Advanced Germ Cell Tumors
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-17
DOI
10.1002/onco.13719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors
- (2019) Samuel A. Funt et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaping-Induced Lung Injury
- (2019) David C. Christiani NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Preliminary Report
- (2019) Jennifer E. Layden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution
- (2018) Clint Cary et al. Clinical Genitourinary Cancer
- Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based Analyses
- (2018) Solomon L. Woldu et al. UROLOGY
- Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students — United States, 2011–2018
- (2018) Karen A. Cullen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors
- (2018) Daniel E. Fein et al. JAMA Oncology
- The Use of “Trend” Statements to Describe Statistically Nonsignificant Results in the Oncology Literature
- (2018) Kevin T. Nead et al. JAMA Oncology
- Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors
- (2016) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines on Testicular Cancer: 2015 Update
- (2015) Peter Albers et al. EUROPEAN UROLOGY
- Large Retroperitoneal Lymphadenopathy As a Predictor of Venous Thromboembolism in Patients With Disseminated Germ Cell Tumors Treated With Chemotherapy
- (2015) Amirrtha Srikanthan et al. JOURNAL OF CLINICAL ONCOLOGY
- Rates of Teratoma and Viable Cancer at Post-Chemotherapy Retroperitoneal Lymph Node Dissection after Induction Chemotherapy for Good Risk Nonseminomatous Germ Cell Tumors
- (2015) Shilajit D. Kundu et al. JOURNAL OF UROLOGY
- The Impact of Bleomycin on Retroperitoneal Histology at Post-Chemotherapy Retroperitoneal Lymph Node Dissection of Good Risk Germ Cell Tumors
- (2015) K. Clint Cary et al. JOURNAL OF UROLOGY
- Testicular Cancer: A Reflection on 50 Years of Discovery
- (2014) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
- (2013) Darren R. Feldman et al. CANCER
- High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
- (2011) Russell A. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
- (2010) Isabelle Boutron JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alternatives to Standard BEP x 3 in Good-Prognosis Germ Cell Tumors--You Bet Your Life
- (2010) C. Nichols et al. JNCI-Journal of the National Cancer Institute
- Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial
- (2010) Peter S. Grimison et al. JNCI-Journal of the National Cancer Institute
- Matching Methods for Causal Inference: A Review and a Look Forward
- (2010) Elizabeth A. Stuart STATISTICAL SCIENCE
- The Total Number of Retroperitoneal Lymph Nodes Resected Impacts Clinical Outcome After Chemotherapy for Metastatic Testicular Cancer
- (2010) Brett S. Carver et al. UROLOGY
- Retroperitoneal lymph node dissection: reassessment of modified templates
- (2009) Michael C. Large et al. BJU INTERNATIONAL
- Retroperitoneal lymph node dissection after chemotherapy
- (2009) Christian Winter et al. BJU INTERNATIONAL
- Weighing Risks and Benefits of Postchemotherapy Retroperitoneal Lymph Node Dissection: Not So Easy
- (2009) George J. Bosl et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery
- (2009) Christian Kollmannsberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients With Disseminated Nonseminomatous Germ Cell Tumors: Is a Postchemotherapy Retroperitoneal Lymph Node Dissection Needed After Complete Remission?
- (2009) Yaron Ehrlich et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started